FDA grants emergency authorization for first COVID-19 breathalyzer test – USA TODAY - 24hrs Trend Plugg

Breaking

CHOOSE YOUR CHOICE GIFT CARD OFFER TODAY

You Have a Chance to Collect $10,000 Now!

Friday, April 15, 2022

FDA grants emergency authorization for first COVID-19 breathalyzer test – USA TODAY

play
Show Caption
Hide Caption

COVID-19 lockdown restrictions ease in Shanghai for some residents

Roughly six million Shanghai residents have been allowed to go outside, though health officials say the virus is not yet contained.

Damien Henderson, Associated Press

Americans will be able to find out if they have COVID-19 with a breathalyzer test, the Food and Drug Administration announced Thursday.

The FDA granted an emergency use authorization to a test produced by InspectIR Systems that collects a breath sample and analyzes for chemical compounds associated with the coronavirus, the first of its kind to be authorized for use.

In a study of 2,409 people, the test correctly identified a positive COVID infection in 91.2% of cases and correctly identified negative samples 99.3% of the time, the FDA said in a release. A similar result was seen in a follow-up study focused on the contagious omicron variant of the coronavirus.

According to InspectIR, the test is performed by exhaling into a tube in a similar manner to blowing up a balloon and produces results within three minutes.

NEW SUBVARIANTS SPREADING IN NEW YORK: Here’s what you need to know

ALREADY GOT COVID? GET VAXXED ANYWAY: Vaccines, boosters up to 68% effective against hospitalization from reinfection, CDC study shows

The FDA said the testing instrument is about the size of a piece of carry-on luggage, and that breath tests can be performed in doctor’s offices, hospitals, and other testing sites. 

“Today’s authorization is yet another example of the rapid innovation occurring with diagnostic tests for COVID-19,” said Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health. “The FDA continues to support the development of novel COVID-19 tests with the goal of advancing technologies that can help address the current pandemic and better position the U.S. for the next public health emergency.” 

The FDA said a positive result yielded through the InspectIR COVID-19 breathalyzer should be confirmed with a molecular test.



from WordPress https://ift.tt/baPimyn
via IFTTT

No comments:

Post a Comment